Jennifer Larson

Researchers defined the association between blood pressure and ibrutinib compared with chemoimmunotherapy in patients with B cell malignancies.

Researchers sought to determine the risk of hepatotoxicity for patients with CML treated with 4 newer TKIs compared with imitanib.

An analysis of data sought to determine the effect of delays related to fertility preservation on the initiation of treatment and overall survival.

Researchers sought to determine the effect of geriatric assessments on conversations and management of comorbidities in older patients with cancer.

A single-center study found anti-COVID-19 protection lowest in patients with MM at 2 weeks after their second BNT162b2 mRNA shot than did patients with myeloproliferative malignancies, and was highest in older patients without cancer.

Results of a survey distributed through the NCCN EHR Oncology Advisory Group showed most clinicians prefer a chronologic format for both others’ notes, as well as their own.

Researchers compared outcomes in patients with PCNSL who did not meet clinical trial criteria with those of patients from a major multicenter clinical trial of PCNSL.

During a residential rehabilitation program, researchers interviewed participants to determine their supportive care and rehabilitation needs.

The American Heart Association released a statement regarding cardiac toxicities and their management in patients with arrhythmic complications while undergoing treatment for cancer.

Researchers offer an introduction to a psychological substudy designed to assess the emotional and psychological experiences of patients with CML considering a TFR attempt.